T Lymphocyte Development — Comprehensive Study Notes

Developmental Goal

  • To generate T cell subsets with functions that allow broad effective defense against microbial infections and tumor development.

Anatomical context and thymic environment

  • Thymus is the site of T cell development.
  • Stable stromal cells provide developmental signals to transient lymphoid cells.
  • T cells migrate from the bone marrow to the thymus.
  • Key thymic factors include thymosin, thymotaxin, thymopoetin, thymic factors, and chemokines.
  • Thymic architecture involves cortex and medulla with an encapsulated organ; thymocytes interact with thymic epithelial cells and antigen-presenting cells (APCs) during maturation.

T cell receptor (TCR) basics

  • Step 1: Ability to recognize antigen via TCR expression on T cells.
  • TCR is the receptor for antigen and comprises variable and constant regions.
  • For the traditional αβ T cells:
    • Antigen binding site built from variable regions of α and β chains.
    • Constant regions form part of the receptor's structure.
    • CD3 complex associates with the TCR and transduces signals (transmembrane region and cytoplasmic tail).
  • There is also a γδ TCR for a subset of T cells (less common in this context):
    • TCR composed of γ and δ chains with similar architecture (variable and constant regions) and CD3.
  • Overall, the specificity of antigen recognition is dictated by the TCR in conjunction with CD3 signaling.
  • Visual cues from slides:
    • For αβ TCR: TCR antigen recognition with an antigen binding site formed by variable regions; α and β chains; CD3 complex linking to intracellular signaling.
    • For γδ TCR: alternative TCR with γ and δ chains and similar signaling components.

Antigen presentation and co-receptors

  • APCs present antigens to T cells via MHC molecules:
    • MHC class I presents to CD8+ T cells in the context of endogenous peptides.
    • MHC class II presents to CD4+ T cells in the context of exogenous peptides (via extracellular processing).
  • T cell activation requires TCR recognition of peptide-MHC and signaling through the CD3 complex.
  • In the synapse: APC/CD4+ T cell interaction is dictated by the TCR and co-receptor engagement (CD4 interacts with MHC II).
  • Notation to remember:
    • ext{MHC-I}
      ightarrow ext{CD8}^+ ext{ T cells}
    • ext{MHC-II}
      ightarrow ext{CD4}^+ ext{ T cells}

Step 2: MHC restriction and thymic learning

  • MHC restriction is learned in the thymus (outside of which peptides are not recognized in this context).
  • Thymic education ensures T cells recognize peptides derived from self-MHC molecules in the context of self peptides during development.

Thymic selection: architecture and processes

  • Incoming thymocytes enter the thymus and progress through cortex and medulla.
  • The Thymus contains capsule, epithelial cells, thymocytes, dendritic cells, and macrophages.
  • Positive selection occurs via interaction with thymic epithelium in the cortex:
    • Thymocytes must recognize self-MHC with appropriate affinity to survive.
  • Negative selection occurs primarily in the medulla to eliminate self-reactive T cells:
    • Thymocytes recognizing self-antigens with high affinity are deleted (apoptosis) or redirected toward tolerance.
  • The thymus is depicted as being “deleted of self-reactivity” through these processes; incoming thymocytes move toward outgoing, mature T cells.
  • Communication among thymic epithelial cells, dendritic cells, macrophages, and thymocytes shapes the repertoire.

Self vs non-self: tolerance induction and AIRE

  • Step 3: Ability to distinguish self from non-self.
  • Central tolerance in the thymus ensures self-t peptides are not presented to mature T cells with strong autoreactivity.
  • Mechanism of tolerance:
    • Self-antigen peptides are presented as MHC complexes during tolerization (a sensitive stage of T cell development).
    • If autoreactive, thymocytes undergo deletion (apoptosis) or are inactivated via other mechanisms.
  • AIRE (Autoimmune Regulator):
    • A transcriptional regulator that enables expression of many tissue-restricted self antigens in MHC+ thymic epithelium.
    • Not a transcription factor; it is a regulator that up-regulates and down-regulates transcription of tissue-restricted antigens and other proteins.
  • Cell types involved in deletion and tolerance in thymus include epithelial cells, dendritic cells, macrophages, and thymocytes.
  • Diagrammatic takeaway: The thymus processes incoming thymocytes through cortical (positive selection) and medullary (negative selection with AIRE involvement) stages to “delete self-reactivity.”

Tolerance outcomes and peripheral regulation

  • Tolerance outcomes can be categorized as:
    • Ignorance (T cells not encountering antigen in a context that triggers activation).
    • Anergy (Functionally inactivated T cells due to insufficient co-stimulation or inhibitory signals).
    • Phenotypic skewing (Differentiation into non-pathogenic helper subsets with non-inflammatory profiles).
    • Apoptosis (Elimination of self-reactive T cells).
  • In tolerized states, inhibitory pathways can be engaged:
    • CTLA-4 interacts with CD80 to dampen activation.
    • PD-1 interacts with PDL1/2 to inhibit TCR signaling.
    • Fas-FasL interactions can drive activation-induced cell death.
  • These regulatory mechanisms are highlighted in Nature Reviews Immunology-style depiction of tolerance pathways.

Step 4: Distinguishing extracellular vs intracellular pathogens and lineage choice

  • Step 4: Ability to distinguish extracellular from intracellular pathogens, often tied to co-receptor expression.
  • Thymocytes that reach the cortex are primarily CD4/CD8 double-positive (DP): extCD4+extCD8+extDPext{CD4}^+ ext{CD8}^+ ext{ DP}
  • In the thymus, DP cells become single-positive (SP) for either CD4 or CD8 depending on which MHC they recognize:
    • CD4+ T cells are Class II restricted (recognize peptides presented by MHC II).
    • CD8+ T cells are Class I restricted (recognize peptides presented by MHC I).
  • Negative selection also occurs to eliminate autoreactive cells during this process.
  • Involves different MHC contexts:
    • Class I MHC restricting CD8+ T cells.
    • Class II MHC restricting CD4+ T cells.
  • Outcome: T cells “learn” to express either CD4+CD4^+ or CD8+CD8^+ during thymic development, based on antigen presentation context.
  • Infections evoke different T cell effector programs depending on MHC class presentation and APC signals.
  • Activated cells include CD8+ cytotoxic T lymphocytes (CTLs) responding to intracellular pathogens and CD4+ helper subsets responding to extracellular or intracellular pathogens depending on the cytokine milieu.

CD4+ T cell differentiation: cytokines and APC guidance

  • What determines which CD4+ T cell sub-subset is favored during a particular infection?
    • The cytokine environment largely dictates subset differentiation (TH1, TH2, TH17, TFH).
    • APCs (antigen-presenting cells) strongly contribute to this cytokine milieu.
  • Pattern Recognition Receptors (PRRs) on APCs recognize Pathogen-Associated Molecular Patterns (PAMPs) and drive APC activation and cytokine production:
    • PRRs on DCs and macrophages bind PAMPs, leading to tailored cytokine responses.
  • Cytokines steering CD4+ T cell development (examples from slides):
    • TH1 differentiation: IL-12 and IFN-γ are often involved (driven by IL-12 and IFN-γ signaling).
    • TH2 differentiation: IL-4 promotes TH2 development.
    • TH17 differentiation: IL-6, TGF-β, and IL-23 contribute to TH17 lineage, with IL-23 reinforcing TH17 maintenance.
    • TFH and other helper pathways are also shaped by cytokine cues and APC signals.
  • Summary: The infection type, engaged PRRs, and the resulting cytokine milieu collectively determine which CD4+ T cell subset predominates.

Putting it all together: the immune orchestration in infection and surveillance

  • A coordinated flow:
    • Bloodstream T cells encounter APCs presenting antigen in regional lymph nodes.
    • T cell activation leads to differentiation into effector T cell subsets (CD4+ helpers and CD8+ CTLs).
    • TH2 and TFH support B cell antibody production; TH1/TH17 aid cell-mediated immunity; CTLs target infected cells.
  • A collaboration between APCs and T cells drives the adaptive response:
    • TH2 and TFH types promote antibody responses; CD8+ cells provide cytotoxic responses.
    • CD4+ TH1/TH17 responses promote inflammatory and cell-mediated responses, crucial for intracellular pathogens.
  • The end goal is effective pathogen clearance while maintaining tolerance to self and minimizing autoimmunity.

Antigen presentation, effector activation, and infection outcomes

  • The form of antigen presentation (MHC class I vs II) dictates the effector pathway activated:
    • Endogenous antigens (intracellular pathogens) are processed via the endogenous pathway and presented on MHC-I to CD8+CD8^+ T cells (CTLs).
    • Exogenous antigens (extracellular pathogens) are processed via the exogenous pathway and presented on MHC-II to CD4+CD4^+ T cells (helpers).
  • The nature of the microenvironment and the pathogen determines whether the response is focused on CTLs or helper T cell-mediated pathways.

Relevance to tumor development and surveillance

  • Positive and negative selection in the thymus helps ensure T cells recognize tumor antigens while avoiding autoimmunity.
  • Tumor cells can express immune checkpoints (e.g., PD-L1) to inhibit T cell responses and promote tumor progression.
  • Tumors evade immune detection by downregulating MHC, reducing T cell recognition.
  • Therapeutic strategies to boost anti-tumor immunity include checkpoint inhibitors that enhance T cell recognition and activation (e.g., PD-1/PD-L1, CTLA-4 blockade).
  • A high mutational burden in tumors increases neoantigen generation, potentially enhancing immune recognition and NK cell activity.
  • Understanding T cell selection and maturation informs approaches to bolster tumor surveillance while minimizing autoimmunity.

Practical implications and caveats

  • Central tolerance via thymic selection is crucial to prevent autoimmunity, but overly stringent selection can limit immune diversity.
  • Peripheral tolerance mechanisms (anergy, regulatory pathways like CTLA-4 and PD-1, Fas–FasL–mediated apoptosis) help control autoimmunity in mature T cells.
  • The balance between effective anti-pathogen/tumor responses and autoimmunity hinges on the complex interplay of TCR specificity, MHC presentation, co-stimulatory/inhibitory signals, and the cytokine milieu.

Miscellanea from the transcript visuals

  • DP thymocytes (ppositive selection focus) are primarily in the cortex; mature SP cells exit via medullary regions after selection.
  • AIRE enables medullary thymic epithelial cells to express tissue-restricted antigens, facilitating central tolerance.
  • The thymus architecture (cortex vs medulla) and cellular players (epithelial cells, dendritic cells, macrophages) underpin the selection and tolerance processes.
  • The overall narrative emphasizes a sequential education (recognize antigen, recognize self-MHC, distinguish self, classify pathogen type) leading to a repertoire capable of defending against infections and surveilling for tumors, while minimizing autoimmunity.

Key terms to remember

  • TCR, αβ T cells, γδ T cells, CD3 complex, MHC I, MHC II, CD4, CD8, DP thymocytes, positive selection, negative selection, AIRE, thymic epithelial cells, dendritic cells, macrophages, CTLA-4, PD-1, PD-L1, Fas, FasL, Th1, Th2, Th17, TFH, PRRs, PAMPs, cytokines (IL-2, IL-12, IFN-γ, IL-6, TGF-β, IL-23, IL-4).